Astellas Pharma gets grant for novel carbocyclic prolinamide derivatives for treating age-related macular degeneration
Discover Astellas Pharma's patented carbocyclic prolinamide derivatives for treating eye diseases like macular degeneration. Explore the unique compound structure and potential applications in pharmaceuticals and beyond.
Discover Astellas Pharma's patented carbocyclic prolinamide derivatives for treating eye diseases like macular degeneration. Explore the unique compound structure and potential applications in pharmaceuticals and beyond.
What's Your Reaction?
